O'Shaughnessy Asset Management, LLC Genfit S.A. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$3.15 - $4.12 $59,289 - $77,546	-18,822 Reduced 58.05%	13,601 $44,000
Q2 2023 Aug 11, 2023	BUY	$3.54 - $4.68 $28,181 - $37,257	7,961 Added 32.54%	32,423 $114,000
Q1 2023 May 12, 2023	BUY	$3.93 - $4.69 $21,929 - $26,170	5,580 Added 29.55%	24,462 $100,000
Q4 2022 Feb 10, 2023	SELL	$3.53 - $4.39 $113,362 - $140,980	-32,114 Reduced 62.97%	18,882 $82,000
Q3 2022 Nov 14, 2022	BUY	$3.26 - $4.86 $166,246 - $247,840	50,996 New	50,996 $186,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.